Acumen Pharmaceuticals Ratios (2020-2026) | ABOS

Ratios Sep2020 Dec2020 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Efficiency
Assets Average (Quarter)
153.90M232.59M225.21M215.88M207.47M199.93M192.23M182.63M231.89M298.25M305.55M294.94M277.94M252.98M221.74M188.19M157.06M132.53M128.23M
Invested Capital (Quarter)
0.76M3.60M8.77M14.12M
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-0.07-171.09365.87-242.26-0.83-0.29124.98-328.38-336.95-109.38-17.77-24.28-31.42682.71-29.69-39.91-24.82-23.18-19.78
Debt Ratio (Quarter)
0.100.100.100.110.120.140.170.220.250.23
Times Interest Earned (Quarter)
-0.07-171.09365.87-242.26-0.83-0.29124.98-328.38-336.95-109.38-17.77-24.28-31.42682.71-29.69-39.91-24.82-23.18-19.78
Valuation
Enterprise Value (Quarter)
-36.80M-198.96M-194.24M-189.09M-189.91M-200.19M-177.60M-140.41M-144.88M-215.43M-242.84M-252.51M-260.47M-199.96M-171.23M-149.15M-143.37M-126.61M-116.86M-128.00M
Return Ratios
Return on Capital Employed (Quarter)
-8.61%-11.30%-15.17%-19.62%-23.55%-26.80%-30.00%-25.20%-21.43%-22.14%-27.43%-36.01%-50.59%-62.55%-88.16%-102.31%-120.79%-115.77%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%